Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab and Pegaspargase with Radiotherapy in Early-Stage ENKTL
NCT04676789Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2021
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT04676789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04676789.